Photodynamic therapy using intra‐articular photofrin for murine MRSA arthritis: Biphasic light dose response for neutrophil‐mediated antibacterial effect
- 15 March 2011
- journal article
- pre clinical
- Published by Wiley in Lasers in Surgery and Medicine
- Vol. 43 (3), 221-229
- https://doi.org/10.1002/lsm.21037
Abstract
Background and Objective Bacterial arthritis does not respond well to antibiotics and moreover multidrug resistance is spreading. We previously tested photodynamic therapy (PDT) mediated by systemic Photofrin® in a mouse model of methicillin‐resistant Staphylococcus aureus (MRSA) arthritis, but found that neutrophils were killed by PDT and therefore the infection was potentiated. Study Design/Materials and Methods The present study used an intra‐articular injection of Photofrin® and optimized the light dosimetry in order to maximize bacterial killing and minimize killing of host neutrophils. MRSA (5 × 107 CFU) was injected into the mouse knee followed 3 days later by 1 µg of Photofrin® and 635‐nm diode laser illumination with a range of fluences within 5 minutes. Synovial fluid was sampled 6 hours or 1–3, 5, and 7 days after PDT to determine MRSA colony‐forming units (CFU), neutrophil numbers, and levels of cytokines. Results A biphasic light dose response was observed with the greatest reduction of MRSA CFU seen with a fluence of 20 J cm−2, whereas lower antibacterial efficacy was observed with fluences that were either lower or higher. Consistent with these results, a significantly higher concentration of macrophage inflammatory protein‐2, a CXC chemokine, and greater accumulation of neutrophils were seen in the infected knee joint after PDT with a fluence of 20 J cm−2 compared to fluences of 5 or 70 J cm−2. Conclusion PDT for murine MRSA arthritis requires appropriate light dosimetry to simultaneously maximize bacterial killing and neutrophil accumulation into the infected site, while too little light does not kill sufficient bacteria and too much light kills neutrophils and damages host tissue as well as bacteria and allows bacteria to grow unimpeded by host defense. Lasers Surg. Med. 43:221–229, 2011.Keywords
Funding Information
- US NIH (RO1AI050875)
- US Air Force MFEL program (FA9550-04-1-0079)
- Center for Integration of Medicine and Innovative Technology (DAMD17-02-2-0006)
- Congressionally Directed Medical Research Program (W81XWH-09-1-0514)
This publication has 38 references indexed in Scilit:
- Can surgical site infections be treated by photodynamic therapy?Photodiagnosis and Photodynamic Therapy, 2010
- Photodynamic therapy for methicillin‐resistant Staphylococcus aureus infection in a mouse skin abrasion modelLasers in Surgery and Medicine, 2010
- In vivo killing of Staphylococcus aureus using a light-activated antimicrobial agentBMC Microbiology, 2009
- Host Defense and Pathogenesis in Staphylococcus aureus InfectionsInfectious Disease Clinics of North America, 2009
- Photodynamic therapy using talaporfin sodium for synovial membrane from rheumatoid arthritis patients and collagen-induced arthritis ratsClinical Rheumatology, 2007
- Photodynamic Therapy Enhancement of Antitumor Immunity Is Regulated by NeutrophilsCancer Research, 2007
- Association between Methicillin Susceptibility and Biofilm Regulation in Staphylococcus aureus Isolates from Device-Related InfectionsJournal of Clinical Microbiology, 2007
- Targeted photodynamic therapy of established soft-tissue infections in micePhotochemical & Photobiological Sciences, 2004
- Progress of Photodynamic Therapy in Gastric CancerDiagnostic and Therapeutic Endoscopy, 1999